Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

SPOTTING the first signs of baldness in the mirror can be a moment of true horror for many men. But could the dreaded bald patch finally be beaten – with lab-grown hair? That’s the potential ...

Based on the NCCN 1.2026 guidelines for the management of CSI seminoma, surveillance is strongly preferred for pT1-pT3 tumors, and the NCCN does not recommend risk-adapted treatment for CSI seminoma ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

Jessica Lougeay-Benson and her husband, David, had just moved their family to Minnesota from Colorado. Having first met at Concordia Language Villages, the couple sought to relocate ...

While the genes involved can differ, this example illustrates how most cancers arise. Accumulated DNA mutations, acquired either over time (ageing naturally leads to some DNA mistakes) or from ...

Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being harmed by over-testing, while those at highest risk are missing out on life ...

A 67-year-old Siliguri resident, after prostate cancer treatment, embraced Ayurveda and yoga for recovery. Within months, his health stabilized and energy improved. Later admitted for cardiac care, he ...

In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...

A real-world comparison of two androgen receptor pathway inhibitors (ARPIs) for advanced prostate cancer showed a significant difference in overall survival (OS). Patients with metastatic ...